Revenue
2009
2018
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | $0 | — | — | — | — | — | — | — | — | $4.7M |
| Research & development | $1.1M | $1.2M | $2.9M | $1.1M | — | — | — | — | — | — | — | — | — | — | — | — |
| Operating expenses | $14.5M | $11.5M | $13.3M | $12.1M | $18.2M | $11.2M | $36.0M | $24.8M | $13.3M | $16.8M | $13.6M | $19.9M | $10.6M | $8.5M | $8.4M | $6.8M |
| Operating income | — | — | — | — | — | −$11.2M | −$36.0M | — | — | — | — | −$19.9M | −$19.6M | −$11.2M | −$12.1M | −$10.2M |
| EBITDAderived | — | — | — | — | — | — | −$35.9M | — | — | — | — | −$19.4M | −$19.0M | −$10.5M | −$11.2M | −$8.9M |
| Net income | −$27.3M | −$12.7M | −$7.8M | −$11.1M | −$16.1M | −$23.6M | −$35.7M | −$19.3M | −$19.6M | −$15.1M | −$10.7M | −$20.3M | — | — | — | — |
| Basic EPSper diluted share | -$0.32 | -$0.22 | -$0.15 | -$0.25 | -$0.49 | -$1.58 | -$38.47 | -$0.78 | -$3.73 | -$5.63 | -$5.28 | -$1.06 | -$1.58 | -$1.18 | -$1.63 | -$0.18 |
| Diluted EPSper diluted share | -$0.32 | -$0.22 | -$0.15 | -$0.25 | -$0.49 | -$1.58 | -$38.47 | -$0.78 | -$3.73 | -$5.63 | -$5.28 | -$1.06 | -$1.58 | -$1.18 | -$1.63 | -$0.18 |
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 1, 2026Form 4 · 10b5-1 | PAGLIARA TRACY DDirector | SellCommon Stock | 26.2K | $0.57 | $15.0K | 923.9K |
| May 29, 2026Form 4 · 10b5-1 | PAGLIARA TRACY DDirector | SellCommon Stock | 4.2K | $0.57 | $2.4K | 950.1K |
| May 28, 2026Form 4 · 10b5-1 | PAGLIARA TRACY DDirector | SellCommon Stock | 19.5K | $0.57 | $11.1K | 954.4K |
| Dec 23, 2024Form 4 | Cryan Terence JamesDirector | BuyCommon Stock | 10.0K | $0.54 | $5.4K | 446.4K |
| Dec 23, 2024Form 4 | Cryan Terence JamesDirector | BuyCommon Stock | 10.0K | $0.54 | $5.4K | 436.4K |